In a report released yesterday, Erin Wright from Morgan Stanley maintained a Buy rating on Zoetis, with a price target of $211.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Erin Wright has given his Buy rating due to a combination of factors that highlight Zoetis’s potential for growth and profitability. Despite recent challenges, such as the lowered 2025 operational revenue guidance and weaker-than-expected performance in the Companion Animal segment, Zoetis’s overall financial health remains robust. The company’s earnings per share exceeded expectations, driven by stronger profitability and favorable tax conditions.
Moreover, Zoetis’s diverse product portfolio and ongoing innovation are seen as significant strengths that differentiate it from competitors. The stock is currently trading at a discount compared to its historical average and peers, which presents an attractive investment opportunity. Wright believes that Zoetis’s exposure to faster-growing and more profitable categories will enhance its market position and drive future growth.
In another report released today, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a $161.00 price target.